Organogenesis (ORGO) Stock Chart & Stock Price History $4.89 +0.42 (+9.40%) Closing price 04:00 PM EasternExtended Trading$4.92 +0.04 (+0.72%) As of 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Organogenesis Stock Price Performance The Organogenesis (ORGO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 77.82%, with a year-to-date return of 52.81%. In the past month, the stock has increased 1.45%, reflecting recent market activity. As of the latest close, Organogenesis traded at $4.47 with a market cap of $567.06 million and volume of 384,724 shares. Five years ago, the stock traded at $4.46, representing a 9.64% increase over that period. At the time, it had a market cap of $470.16 million and a volume of 79,299 shares. Receive ORGO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Organogenesis and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.38%1 Month Performance+1.45%3 Month Performance+64.65%Year-To-Date Performance+52.81%1 Year Performance+77.82%5 Year Performance+9.64% ORGO Stock Chart for Friday, August, 22, 2025 ORGO Chart by TradingView Organogenesis Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$4.58$4.47-2.40%$4.58$4.44384,724 shs$567.06 million08/20/2025$4.48$4.58+2.23%$4.61$4.41356,124 shs$581.02 million08/19/2025$4.58$4.48-2.18%$4.75$4.46490,647 shs$568.32 million08/18/2025$4.73$4.58-3.17%$4.75$4.55306,228 shs$581.02 million08/15/2025$4.70$4.73+0.64%$4.90$4.69520,504 shs$600.05 million08/14/2025$4.91$4.70-4.28%$4.86$4.65472,993 shs$596.24 million08/13/2025$4.89$4.91+0.41%$5.00$4.82592,498 shs$622.87 million08/12/2025$4.61$4.89+6.07%$4.94$4.46874,898 shs$620.35 million08/11/2025$4.55$4.61+1.32%$4.82$4.52746,740 shs$584.83 million08/08/2025$4.52$4.55+0.66%$4.67$3.581.39 million shs$577.17 million Get the Latest News and Ratings for ORGO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Organogenesis and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$4.50$4.52+0.44%$4.72$4.46806,081 shs$573.38 million08/06/2025$4.53$4.50-0.66%$4.59$4.47832,000 shs$570.83 million08/05/2025$4.60$4.53-1.52%$4.67$4.50461,655 shs$574.63 million08/04/2025$4.51$4.60+2.00%$4.69$4.48739,554 shs$583.53 million08/01/2025$4.62$4.51-2.38%$4.61$4.361.55 million shs$572.09 million07/31/2025$4.66$4.62-0.86%$4.72$4.57439,419 shs$586.07 million07/30/2025$4.77$4.66-2.31%$4.82$4.59486,473 shs$591.12 million07/29/2025$5.02$4.77-4.98%$5.08$4.76321,484 shs$605.07 million07/28/2025$5.03$5.02-0.20%$5.15$4.92610,434 shs$636.81 million07/25/2025$4.75$5.03+5.89%$5.04$4.671.35 million shs$638.08 million07/24/2025$4.98$4.75-4.62%$4.96$4.74506,413 shs$602.54 million07/23/2025$4.82$4.98+3.32%$5.02$4.82646,242 shs$631.71 million07/22/2025$4.56$4.82+5.70%$4.91$4.55774,812 shs$611.44 million07/21/2025$4.37$4.56+4.35%$4.59$4.30956,494 shs$578.44 million Related Companies ImmunityBio Stock Price Chart Centessa Pharmaceuticals Stock Price Chart Arrowhead Pharmaceuticals Stock Price Chart Belite Bio Stock Price Chart Recursion Pharmaceuticals Stock Price Chart Bausch Health Cos Stock Price Chart Ocular Therapeutix Stock Price Chart Agios Pharmaceuticals Stock Price Chart Denali Therapeutics Stock Price Chart IDEAYA Biosciences Stock Price Chart Receive ORGO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Organogenesis and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORGO) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organogenesis Please log in to your account or sign up in order to add this asset to your watchlist. Share Organogenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access